Cargando…

The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy

Great effort has been devoted to the synthesis of novel multi-target directed tacrine derivatives in the search of new treatments for Alzheimer’s disease (AD). Herein we describe the proof of concept of MBA121, a compound designed as a tacrine–ferulic acid hybrid, and its potential use in the therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez-Ruiz, Emelina R., Herrero-Labrador, Raquel, Fernández-Fernández, Ana P., Serrano-Masa, Julia, Martínez-Montero, José A., González-Nieto, Daniel, Hana-Vaish, Mayuri, Benchekroun, Mohamed, Ismaili, Lhassane, Marco-Contelles, José, Martínez-Murillo, Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419016/ https://www.ncbi.nlm.nih.gov/pubmed/37569630 http://dx.doi.org/10.3390/ijms241512254

Ejemplares similares

Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
por: Dgachi, Youssef, et al.
Publicado: (2018)

ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy
por: Marco-Contelles, José, et al.
Publicado: (2016)

Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors
por: Svobodova, Barbora, et al.
Publicado: (2019)

Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease
por: Zhu, Jie, et al.
Publicado: (2018)

Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids as Multifunctional Drug Candidates against Alzheimer’s Disease
por: Fu, Yingbo, et al.
Publicado: (2016)

Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities
por: Chrienova, Zofia, et al.
Publicado: (2022)

Development of tacrine clusters as positively cooperative systems for the inhibition of acetylcholinesterase
por: Evangelista, Tereza Cristina Santos, et al.
Publicado: (2021)

Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers
por: Vaaland, I. Caroline, et al.
Publicado: (2022)

QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease Therapy
por: Ramos, Eva, et al.
Publicado: (2019)

The Mobile MBA
por: Owen, Jo
Publicado: (2010)

Ferulic acid derivatives block coronaviruses HCoV-229E and SARS-CoV-2 replication in vitro
por: Pasquereau, Sébastien, et al.
Publicado: (2022)

Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties
por: Choura, Emna, et al.
Publicado: (2022)

Tacrine-6-Ferulic Acid, a Novel Multifunctional Dimer, Inhibits Amyloid-β-Mediated Alzheimer's Disease-Associated Pathogenesis In Vitro and In Vivo
por: Pi, Rongbiao, et al.
Publicado: (2012)

The portable MBA in marketing /
por: Hiam, Alexander
Publicado: (1992)

El MBA portátil
Publicado: (1994)

The Every Day MBA
por: Dalton, Chris
Publicado: (2015)

The Wall Street MBA
por: Advani, Reuben
Publicado: (2012)

Key MBA Models
por: Mark, Ken
Publicado: (2015)

Therapeutic Potential of Multifunctional Tacrine Analogues
por: Przybyłowska, Maja, et al.
Publicado: (2019)

Editorial: Advances in drug discovery for anti-Alzheimer’s agents
por: Ismaili, Lhassane
Publicado: (2022)

N-Hydroxy-N-Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases
por: Bautista-Aguilera, Óscar M., et al.
Publicado: (2022)

Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer’s Disease Therapy
por: Zribi, Lazhar, et al.
Publicado: (2020)

QSAR analysis on tacrine-related acetylcholinesterase inhibitors
por: Wong, Kai Y, et al.
Publicado: (2014)

Tacrine-Based Hybrids: Past, Present, and Future
por: Bubley, Anna, et al.
Publicado: (2023)

Tú propio MBA : Lo que se aprende en un MBA por el precio de un libro /
por: Kaufman, Josh
Publicado: (2018)

Formulation, Characterization and Evaluation against SH-SY5Y Cells of New Tacrine and Tacrine-MAP Loaded with Lipid Nanoparticles
por: Silva, Sara, et al.
Publicado: (2020)

The fast forward MBA in project management
por: Verzuh, Eric
Publicado: (2015)

The Fast Forward MBA in Project Management
por: Verzuh, Eric
Publicado: (2011)

The Pragmatic MBA for Scientific and Technical Executives
por: Liang, Bertrand
Publicado: (2012)

The Fast Forward MBA in Project Management
por: Verzuh, Eric
Publicado: (2008)

The Fast Forward MBA in Project Management
por: Verzuh, Eric
Publicado: (2021)

25 Need-to-Know MBA Models
por: Birkinshaw, Julian
Publicado: (2017)

Mesures magnétiques d'aimants dipôles de type MBA révisés (MBA 005, 244, 297, 375)
por: Dutour, J
Publicado: (2000)

Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s Disease
por: Dgachi, Youssef, et al.
Publicado: (2016)

Postischemic Neuroprotection of Aminoethoxydiphenyl Borate Associates Shortening of Peri-Infarct Depolarizations
por: Fernández-Serra, Rocío, et al.
Publicado: (2022)

Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer′s Disease Therapy
por: Boulebd, Houssem, et al.
Publicado: (2016)

Synthesis of Hantzsch Adducts as Cholinesterases and Calcium Flux inhibitors, Antioxidants and Neuroprotectives
por: Pachón Angona, Irene, et al.
Publicado: (2020)

MBA: theory and application of business and management principles
por: Machado, Carolina, et al.
Publicado: (2016)

Respuestas rápidas para el programa MBA /
por: Shim, Jae K.
Publicado: (2000)

Conjugates of Tacrine with Salicylamide as Promising Multitarget Agents for Alzheimer's Disease
por: Grishchenko, Maria V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4e9f10lp0e7buuta8fqtlad6ug